Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Stolla, Moritz ^a   Pelisek, Jaroslav ^b   von Brühl, Marie Luise ^b,c   Schäfer, Andreas ^d   Barocke, Verena ^b,c   Heider, Peter ^b   Lorenz, Michael ^b,c   Tirniceriu, Anca ^b,c   Steinhart, Alexander ^b,c   Bauersachs, Johann ^d   Bray, Paul F ^a   Massberg, Steffen ^b,c   Schulz, Christian ^b,c,e  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Munich Heart Alliance   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; BLOOD VESSEL WALL; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CELL ADHESION; CELL COUNT; CELL TRANSPORT; CONTROLLED STUDY; CORRELATION ANALYSIS; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS;

ANIMALS; ATHEROSCLEROSIS; CELLS, CULTURED; CHEMOKINE CX3CL1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; POLYMERASE CHAIN REACTION; RECEPTORS, CHEMOKINE;

EID: 84865181707     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043572     Document Type: Article

References (51)

1. Damas JK, Waehre T, Yndestad A, Otterdal K, Hognestad A, et al. ((2003)) Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets. Circulation 107:: 2670--2676.
2. Yi GW, Zeng QT, Mao XB, Cheng M, Yang XF, et al. ((2011)) Overexpression of CXCL16 promotes a vulnerable plaque phenotype in Apolipoprotein E-Knockout Mice. Cytokine 53:: 320--326.
3. de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, et al. ((2003)) Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 107:: 690--695.
4. Greaves DR, Hakkinen T, Lucas AD, Liddiard K, Jones E, et al. ((2001)) Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 21:: 923--929.
5. Damas JK, Boullier A, Waehre T, Smith C, Sandberg WJ, et al. ((2005)) Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy. Arterioscler Thromb Vasc Biol 25:: 2567--2572.
6. Wong BW, Wong D, McManus BM, ((2002)) Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease. Cardiovasc Pathol 11:: 332--338.
7. Combadiere C, Potteaux S, Gao JL, Esposito B, Casanova S, et al. ((2003)) Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 107:: 1009--1016.
8. Lesnik P, Haskell CA, Charo IF, ((2003)) Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J Clin Invest 111:: 333--340.
9. Teupser D, Pavlides S, Tan M, Gutierrez-Ramos JC, Kolbeck R, et al. ((2004)) Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root. Proc Natl Acad Sci U S A 101:: 17795--17800.
10. McDermott DH, Fong AM, Yang Q, Sechler JM, Cupples LA, et al. ((2003)) Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J Clin Invest 111:: 1241--1250.
11. McDermott DH, Halcox JP, Schenke WH, Waclawiw MA, Merrell MN, et al. ((2001)) Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ Res 89:: 401--407.
12. Moatti D, Faure S, Fumeron F, Amara Mel W, Seknadji P, et al. ((2001)) Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97:: 1925--1928.
13. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, et al. ((1997)) A new class of membrane-bound chemokine with a CX3C motif. Nature 385:: 640--644.
14. Moore KJ, Tabas I, ((2011)) Macrophages in the pathogenesis of atherosclerosis. Cell 145:: 341--355.
15. Potteaux S, Gautier EL, Hutchison SB, van Rooijen N, Rader DJ, et al. ((2011)) Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression. J Clin Invest 121:: 2025--2036.
16. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, et al. ((1997)) Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91:: 521--530.
17. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, et al. ((2007)) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117:: 185--194.
18. Galkina E, Harry BL, Ludwig A, Liehn EA, Sanders JM, et al. ((2007)) CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall. Circulation 116:: 1801--1811.
19. Galkina E, Kadl A, Sanders J, Varughese D, Sarembock IJ, et al. ((2006)) Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J Exp Med 203:: 1273--1282.
20. Choi YS, Kageyama R, Eto D, Escobar TC, Johnston RJ, et al. ((2011)) ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity 34:: 932--946.
21. Virmani R, Burke AP, Farb A, Kolodgie FD, ((2006)) Pathology of the vulnerable plaque. J Am Coll Cardiol 47:: C13--18.
22. Egorina EM, Sovershaev MA, Bjorkoy G, Gruber FX, Olsen JO, et al. ((2005)) Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability. Arterioscler Thromb Vasc Biol 25:: 1493--1498.
23. Crouse JR 3rd, Thompson CJ, ((1993)) An evaluation of methods for imaging and quantifying coronary and carotid lumen stenosis and atherosclerosis. Circulation 87:: II17--33.
24. Hasegawa M, Sato S, Echigo T, Hamaguchi Y, Yasui M, et al. ((2005)) Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis. Ann Rheum Dis 64:: 21--28.
25. Schulz C, Penz S, Hoffmann C, Langer H, Gillitzer A, et al. ((2008)) Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo. Basic Res Cardiol 103:: 356--367.
26. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, et al. ((1994)) A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 89:: 2462--2478.
27. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, et al. ((1995)) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92:: 1355--1374.
28. Lucas AD, Bursill C, Guzik TJ, Sadowski J, Channon KM, et al. ((2003)) Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1). Circulation 108:: 2498--2504.
29. Bibikova M, Talantov D, Chudin E, Yeakley JM, Chen J, et al. ((2004)) Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays. Am J Pathol 165:: 1799--1807.
30. Specht K, Richter T, Muller U, Walch A, Werner M, et al. ((2001)) Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am J Pathol 158:: 419--429.
31. Schmittgen TD, Livak KJ, ((2008)) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:: 1101--1108.
32. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, et al. ((2007)) Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317:: 666--670.
33. Walker EB, Lanier LL, Warner NL, ((1982)) Characterization and functional properties of tumor cell lines in accessory cell replacement assays. J Immunol 128:: 852--859.
34. Robinson LA, Nataraj C, Thomas DW, Howell DN, Griffiths R, et al. ((2000)) A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J Immunol 165:: 6067--6072.
35. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R, ((1994)) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14:: 133--140.
36. Massberg S, Schurzinger K, Lorenz M, Konrad I, Schulz C, et al. ((2005)) Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation 112:: 1180--1188.
37. Massberg S, Brand K, Gruner S, Page S, Muller E, et al. ((2002)) A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 196:: 887--896.
38. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, et al. ((2000)) Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 20:: 4106--4114.
39. Massberg S, Konrad I, Schurzinger K, Lorenz M, Schneider S, et al. ((2006)) Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 203:: 1221--1233.
40. Massberg S, Gawaz M, Gruner S, Schulte V, Konrad I, et al. ((2003)) A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 197:: 41--49.
41. Schulz C, von Bruhl ML, Barocke V, Cullen P, Mayer K, et al. ((2011)) EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall. J Thromb Haemost 9:: 1007--1019.
42. Robinson LA, Nataraj C, Thomas DW, Cosby JM, Griffiths R, et al. ((2003)) The chemokine CX3CL1 regulates NK cell activity in vivo. Cell Immunol 225:: 122--130.
43. Ludwig A, Weber C, ((2007)) Transmembrane chemokines: versatile 'special agents' in vascular inflammation. Thromb Haemost 97:: 694--703.
44. Umehara H, Goda S, Imai T, Nagano Y, Minami Y, et al. ((2001)) Fractalkine, a CX3C-chemokine, functions predominantly as an adhesion molecule in monocytic cell line THP-1. Immunol Cell Biol 79:: 298--302.
45. Fong AM, Robinson LA, Steeber DA, Tedder TF, Yoshie O, et al. ((1998)) Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med 188:: 1413--1419.
46. Kim KW, Vallon-Eberhard A, Zigmond E, Farache J, Shezen E, et al. (2011) In vivo structure/function and expression analysis of the CX3C chemokine fractalkine. Blood.
47. Schulz C, Schafer A, Stolla M, Kerstan S, Lorenz M, et al. ((2007)) Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets. Circulation 116:: 764--773.
48. Kerfoot SM, Lord SE, Bell RB, Gill V, Robbins SM, et al. ((2003)) Human fractalkine mediates leukocyte adhesion but not capture under physiological shear conditions; a mechanism for selective monocyte recruitment. Eur J Immunol 33:: 729--739.
49. Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie BC, et al. ((2004)) Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 104:: 3190--3197.
50. Ikejima H, Imanishi T, Tsujioka H, Kashiwagi M, Kuroi A, et al. ((2010)) Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris. Circ J 74:: 337--345.
51. Dorgham K, Ghadiri A, Hermand P, Rodero M, Poupel L, et al. ((2009)) An engineered CX3CR1 antagonist endowed with anti-inflammatory activity. J Leukoc Biol 86:: 903--911.